申请人:Setoh Masaki
公开号:US20100041891A1
公开(公告)日:2010-02-18
A compound having GPR52 agonist activity or a salt thereof is provided.
The compound can be provided as a preventive/therapeutic agent for schizophrenia or the like. The compound is represented by the following formula:
wherein
A represents —CONR
a
— or —NR
a
CO—,
R
a
represents a hydrogen atom or the like,
B represents a hydrogen atom or the like,
a ring Cy1 represents a six-membered aromatic ring which may have one or more substituents in addition to a group represented by -A-B,
a ring Cy2 represents a six-membered ring which may be substituted with a halogen atom or the like,
a ring Cy3 represents a five- or six-membered ring which may have one or more substituents;
X represents C
1-2
alkylene or the like,
m represents an integer of 0 to 2, and
a ring Cy4 represents a six-membered aromatic ring which may have one or more substituents.
提供具有GPR52激动剂活性或其盐的化合物。该化合物可作为预防/治疗精神分裂症等疾病的药物。该化合物由以下公式表示:其中A代表—CONRa—或—NRaCO—,Ra代表氢原子或类似物质,B代表氢原子或类似物质,环Cy1代表一个六元芳香环,除了由-A-B表示的基团外,可能有一个或多个取代基,环Cy2代表一个六元环,可能被卤素原子或类似物质取代,环Cy3代表一个有一个或多个取代基的五元或六元环;X代表C1-2烷基或类似物质,m代表0到2之间的整数,环Cy4代表一个六元芳香环,可能有一个或多个取代基。